EXHIBIT 10.3 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN MILLENNIUM PHARMACEUTICALS, INC.License, Development and Commercialization Agreement • August 4th, 2004 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
May 27, 2004 Anna Protopapas Vice President, Corporate Development Millennium Pharmaceuticals, Inc. 75 Sidney Street Cambridge, Massachusetts 02139 Re: Early Distribution of Program Target and Compound Assets Dear Anna: Reference is made to the...Collaboration and License Agreement • August 4th, 2004 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT NO. 10.2 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. AGREEMENT ABOUT EUROPEAN COMMERCIALIZATION OF INTEGRILINAgreement About European Commercialization of Integrilin • August 4th, 2004 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
